ArticleJournal of neurosurgery. Case lessons2026
Malignant peripheral nerve sheath tumors arising in SMARCB1-associated schwannomatosis: illustrative cases.
Article in Journal of neurosurgery. Case lessons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSchwannomatosis is a rare tumor predisposition syndrome characterized by benign peripheral nerve sheath tumors in the absence of bilateral vestibular schwannomas. In rare cases, malignant peripheral nerve sheath tumors (MPNSTs) may arise with schwannomatosis, particularly with SMARCB1 mutations. These malignancies pose significant diagnostic and therapeutic challenges and a poor prognosis. OBSERVATIONS: The authors present 2 cases of high-grade MPNST with SMARCB1-associated schwannomatosis. Both presented with rapidly enlarging and concerning imaging features, including heterogeneous enhancement, central necrosis, and low apparent diffusion coefficient values. Histopathological analysis confirmed high-grade MPNST with elevated mitotic activity and loss of H3K27me3. Both patients underwent en bloc resection with negative margins. One patient remains disease free at 5 years; the other patient developed metastatic recurrence and died. A systematic review identified 20 cases in the literature. LESSONS: These cases emphasize clinical vigilance for malignant transformation in schwannomatosis, particularly with rapidly enlarging lesions or new neurological symptoms. MRI and FDG-PET can aid in identifying concerning features. Despite margin-negative resection, recurrence and metastasis may occur, reflecting the tumor's aggressive biology. Genetic counseling may be considered in SMARCB1-associated cases. While malignant transformation is much more common in NF1 lesions, rare cases do arise in schwannomatosis, requiring close surveillance and multidisciplinary management. https://thejns.org/doi/10.3171/CASE25610.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.